| Literature DB >> 35637836 |
Mohammad Al-Kadi1, Mohamed A Alfawaz2, Fahad Z Alotaibi3.
Abstract
One of the most prevalent pediatric ailments around the world is voice disorders. Around 5-million children suffer from voice disorders, and three out of five of them suffer from vocal nodule-induced persistent dysphonia. Nineteen out of 20 otolaryngologists recommend voice therapies for the treatment of pediatric vocal fold nodules. However, the benefits of these therapies still remain to be assessed systematically. The objective of this study is to systematically review the impact of voice therapy (direct and indirect) on pediatric patients with vocal nodules. In this systematic review of randomized control trials (RCTs), four electronic databases, PubMed, CENTRAL (Cochrane), Science Direct, and Lancet, were explored for the literature survey. The impact of direct and indirect voice therapies on pediatric cases with vocal nodules was reviewed based on the results of the selected articles. Based on stringent inclusion and exclusion criteria, six articles were selected. All these studies examined the effects of direct and indirect voice therapies on two types of voice disorders, that is, dysphonia and vocal nodules. Only one of the six studies reported significant alleviation of the patient condition post-intervention. However, none of the studies discussed the clinical significance of the interventions. Three of the six included studies used both direct and indirect voice therapies and reported substantial differences in the data collected before and after the interventions. However, overall, the studies reported more significant improvements in patient conditions. More studies in this domain are still warranted, especially to help understand and define the meaning of the term "effectiveness" with respect to voice therapies.Entities:
Keywords: dysphonia; pediatric; vocal nodules; voice therapies; voice therapy
Year: 2022 PMID: 35637836 PMCID: PMC9128307 DOI: 10.7759/cureus.24433
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
PICO method used in this study
PICO: P - Population; I - Intervention; C - Comparator; O - Outcome(s)
| PICO | |
| Population | Children With Vocal Nodules |
| Intervention | Direct Voice Therapy |
| Comparator | Indirect Voice Therapy |
| Outcome | Pediatric Quality of Life Scale (PVRQOL) or GRBAS (Grade, Roughness, Breathiness, Asthenia, and Strain) Scale or Consensus Auditory Perceptual Evaluation of Voice (CAPE-V) |
Search strategies used for the different databases
| Database | Search Engines | Result |
| PubMed | (Vocal) OR (Larynx)) OR (Laryngeal)) OR (Voice)) OR (Nodules))) AND (Therapy)) OR (Voice Assessment)) OR (Indirect Therapy)) AND (Direct Therapy)) AND (Indirect and Direct Therapy)) OR (Voice Outcome)) | 670 |
| ScienceDirect | "Vocal Nodules" OR ("Larynx" OR "Laryngeal") AND "Voice Assessment" OR "Indirect Therapy" AND "Direct Therapy" AND "Indirect and Direct Therapy" OR "Voice Outcome" | 96 |
| CENTRAL (Cochrane) | "Vocal Nodules" OR "Larynx" OR "Laryngeal" AND "Voice Assessment" OR "Indirect Therapy" AND "Direct Therapy" AND "Indirect and Direct Therapy" OR "Voice Outcome" | 178 |
| Lancet | "Vocal" OR "Larynx" OR "Laryngeal" OR "Voice" OR "Nodules" AND "Therapy" OR "Voice Assessment" OR "Indirect Therapy" AND "Direct Therapy" AND "Indirect and Direct Therapy" OR "Voice Outcome" | 172 |
Eligibility criteria in our study
| Inclusion Criteria | Exclusion Criteria |
| Publication | |
| Written in the English language | Dissertations, editorials, doctorates, and gray literature |
| Published between January 2001 and May 2021 | Difficult to access articles |
| Peer-reviewed articles published in an indexed scientific journal | Incomplete trials |
| Patient cohort | |
| Studies comprising cohort aged <18 years | Studies comprising cohort aged >18 years |
| Participants in the studies previously underwent voice therapy | |
| Animal or cadaver studies | |
| Intervention | |
| Studies including direct and indirect voice therapies as interventions (irrespective of duration, intensity, or type of voice therapy) | All studies including therapies other than direct and indirect voice therapies |
| Design | |
| Randomized controlled trials (RCTs), cluster RCTs, quasi-RCTs, and randomized cross-over trials | Tool development studies |
| Interventions comprise ≥5 participants per group | Validity studies |
| Outcome measures | |
| Articles that indicated the use of scale-related voice quality measures such as self-reported measures, observer-rated measures, and instrumental measures | - |
Factors affecting the filtering of studies
| Title and abstract screening | Full-text screening |
| cohort with age > 18 years | no details regarding the voice therapy intervention used |
| animal studies | |
| vocal fold ailments other than nodules | |
| did not use voice therapy as the intervention | comprising other ailments and therapies |
| non-English | |
| editorials | |
| outside inclusion criteria period |
Figure 1PRISMA flow diagram of the initial search strategy and screening process
PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-Analyses
Figure 2Risk of bias assessment
Other biases include Selection bias, Information bias, and Confounding bias.
[1-6]